Vitality Biopharma shareholders elect directors and approve 2021 Stock Incentive Plan at annual meeting.

RANGE IMPACT, INC.

Edward Feighan, Richard Celeste, Michael Cavanaugh elected as directors with >98% votes for.
2021 Stock Incentive Plan approved: 21,209,644 votes for, 638,306 against.
Advisory vote on executive compensation approved: 21,298,713 for, 523,948 against.
Stockholders preferred advisory votes on exec comp every 3 years (21,021,589 votes); board adopted that frequency.
Ratification of Meaden & Moore as auditor: 27,454,815 for, 101,379 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.